Glycolipids and myelin proteins in human oligodendrogliomas

Glycoconjugate Journal

Volumn 13, Issue 3, 1996, Pages 433-443

  Sung, C C ^a   Collins, R ^a   Li, J ^a   Pearl, D K ^a   Coons, Stephen W ^b   Scheithauer, Bernd W ^c   Johnson, Peter C ^b   Yates, A J ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c MAYO CLINIC   (United States)

Author keywords

brain tumours; gangliosides; glioma; glycolipids; myelin proteins

Indexed keywords

GANGLIOSIDE; MYELIN PROTEIN;

ARTICLE; CANCER GRADING; HUMAN; HUMAN TISSUE; MYELINATION; OLIGODENDROGLIA; OLIGODENDROGLIOMA; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; TUMOR CLASSIFICATION;

BRAIN NEOPLASMS; CARBOHYDRATE CONFORMATION; CARBOHYDRATE SEQUENCE; GANGLIOSIDES; GLYCOLIPIDS; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; MYELIN PROTEINS; N-ACETYLNEURAMINIC ACID; OLIGODENDROGLIOMA;

EID: 0029975461     PISSN: 02820080     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00731476     Document Type: Article

References (36)

1. Russel DS, Rubinstein LJ (1989) Pathology of Tumors of the Nervous System. Baltimore: Williams & Williams.
2. Bailey P, Cushing H (1926) A Classification of Tumors of the Glioma Group on a Histogenetic Basis with a Correlated Study of Prognosis. Philadelphia, London, Montreal: Lippincott.
3. Ogawa H, Sato Y, Takeshita I, Kitamura K (1985) Dev Brain Res 18: 133-41.
4. Choi BH, Kim RC (1984) Science 223: 407-9.
5. Herpers MJHM, Budka H (1984) Acta Neuropathol 64: 265-72.
6. Nakagawa Y, Perentes E, Rubinstein LJ (1986) Acta Neuropathol 72: 15-22.
7. Jagadha V, Halliday WC, Becker LE (1986) Can J Neurol Sci 13: 307-11.
8. Kamitani H, Masuzawa H, Sato J, Kanazawa I (1988) J Neurol Sci 83: 219-25.
9. Kros JM, De Jong AAW, Van Der Kwast TH (1992) J Neuropathol Exp Neurol 51: 186-93.
10. Bansal R, Pfeiffer SE (1992) J Neurosci Res 32: 309-16.
11. Myoga A, Taki T, Arai K, Sekiguchi K, Ikeda I, Kurata K, Matsumoto M (1988) Cancer Res 48: 1512-16.
12. Ledeen RW, Yu RK (1982) Methods Enzymol 83: 139-91.
13. Sung CC, Pearl DK, Coons SW, Scheithauer BW, Johnson PC, Yates AJ (1994) Cancer 74: 3010-22.
14. Folch J, Lees M, Sloane Stanley GH (1957) J Biol Chem 226: 497-509.
15. Saito T, Hakomori S-I (1971) J Lipid Res 12: 257-59.
16. Svennerholm L (1957) Biochim Biophys Acta 24: 604-11.
17. Miettinen T, Takki-Luukkainen IT (1959) Acta Chem Scand 13: 856-885.
18. Buehler J, Macher BA (1986) Anal Biochem 158: 283-87.
19. Li J, Pearl DK, Pfeiffer SE, Yates AJ (1994) J Neurosci Res 39: 148-58.
20. Kennedy PGE, Watkins BA, Thomas DGT, Noble MD (1987) Neuropathol Appl Neurobiol 13: 327-47.
21. Sung C-C, Pearl DK, Coons SW, Scheithauer BW, Johnson PC, Zheng M, Yates AJ (1995) Cancer 75: 851-59.
22. Singh LPK, Pearl DK, Franklin TK, Spring PM, Scheithauer BW, Coons SW, Johnson PC, Pfeiffer SE, Li J, Knott JCA, Yates AJ (1994) Mol Chem Neuropathol 21: 241-57.
23. Nojiri H, Stroud M, Hakomori S-I (1991) J Biol Chem 266: 4531-37.
24. Hakomori S (1990) J Biol Chem 265: 18713-16.
25. Hanai H, Nores GA, MacLeod C, Torres-Mendez C-R, Hakomori S-I (1988) J Biol Chem 263: 10915-21.
26. Paller AS, Arnsmeier SL, Alvarez-Franco M, Bremer EG (1993) J Invest Dermatol 100: 841-15.
27. Van Brocklyn J, Bremer EG, Yates AJ (1993) J Neurochem 61: 371-74.
28. Rabin SJ, Mocchetti I (1995) J Neurochem 65: 347-54.
29. Yates AJ, Saqr HE, Van Brooklyn J (1995) J Neuro-Oncol 24: 65-73.
30. Hakomori SI (1981) Annu Rev Biochem 50: 733-64.
31. Hakomori SI (1985) In Molecular Biology of Tumor Cells (Wahern B, Hammarstrom S, Holm G, Perlmann P, eds) p. 139-156. New York: Raven Press.
32. Figols J, Iglesias-Rozas JR, Kazner E (1985) Clin Neuropathol 4: 116-20.
33. Raff MC, Abney ER, Cohen J, Lindsay R, Noble M (1983) J Neurosci 3: 1289-1300.
34. Li Y, Atashi C, Hayes C, Reap S, Hunt S III, Popko B (1995) J Neurosci Res 40: 189-98.
35. Choi BH, Kim RC (1985) J Neuroimmunol 8: 215-35.
36. Min K-W, Scheithauer BW (1994) Ultrastruct Pathol 18: 47-60.